The London Stock Exchange isn’t packed to the brim with what some call ‘unicorn’ stocks, but this FTSE 250 biotech firm looks ...

Rapid advances in synthetic biology are radically transforming multiple domains, including healthcare, agriculture, environmental management, and industrial ...